3 Valuable Lessons Learned From the Marijuana Stock Crash of 2019

What goes up, must come down. Looking back on 2019, the marijuana market was in a huge bubble. Could Aurora stock be the company that climbs out first?

| More on:
Photo of a floating bubble

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

You may remember the buzz and excitement among investors two years ago, ahead of the blanket legalization of cannabis in Canada. Now, two years later, we are standing at the other side of that excitement – wiser, and ready to learn from the full trajectory of cannabis stocks: from colossal high to epic fall.

Cannabis stocks crashed last year and it was widespread. Just look at the stocks of any cannabis company in the last six months, and you will see a dismal performance. Canopy Growth Corp plunged from $52.49 to $27.31. Aurora Cannabis (TSX:ACB)(NYSE:ACB) nosedived from $10 to $2.79. HEXO Corp crashed to $2.07 from $6.80. You get the point.

So, what to learn here? Let’s have a look at the three big takeaways from 2019’s cannabis stock crash.

Overvalued stocks crash sooner or later

We all know that every year or two a wave comes along with hyperbolic claims about being “the next big thing” in the market. From cryptocurrency to the blockchain to AI, we have witnessed many such fads in this century alone. I am not drawing any parallel here, but investors hyped cannabis stocks in a similar manner leading up to legalization in Canada.

This hype resulted in the overvaluation of nearly every cannabis stock. Aurora Cannabis became the most significant cannabis company in the country and went on to become the most sought-after stock in North America. After the sobering previous year, Aurora’s stock price is still 10 times its earnings. This price-to-earnings ratio was much higher six months ago.

As the high of cannabis legalization started waning, courtesy of the contrasting reality on the ground, the market maintained its order and “reset” cannabis stock prices.

Overproduction can kill stocks

Cannabis stocks are not retail stocks per se. However, the stock performance is hugely dependent on retail sales, and that is where the problem lies. Canadian demand for pot, in comparison to its production, was not as high as it was projected to be. Cannabis companies invested millions in farms, greenhouses, and storage facilities with this projection in mind.

Now these facilities are underused and only adding up to fiscal losses. The overproduction has affected Aurora Cannabis so much that it had to get rid of US$20 million worth of pot, cheaply.

Cannabis stocks are a good buy if you are in for the long term

Despite the bearish performance of the last year, the long-term viability and profitability of cannabis stocks can’t be ruled out. Compared to established industries that have been around for decades, the cannabis landscape is still in its infancy.

Once regulators fix their red-tape issues and cannabis companies get beyond “too good to be true” valuations, cannabis stocks will get out of their current bearish trend.

Summary

The crash of overvalued cannabis stocks was always on the cards, and was further aggravated by the lukewarm demand for legalized pot. But I think it has been a first big lesson for cannabis companies. With the legalized cannabis market spreading worldwide, one could easily imagine that the future of cannabis stocks is not that bleak.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jason Hoang has no position in any of the stocks mentioned. The Motley Fool recommends and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »